Cowen And Company, LLC Biogen Inc. Call Options Transaction History

Cowen And Company, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 09, 2023	BUY	$252.44 - $306.72 $2.75 Million - $3.34 Million	10,900 New	10,900 $3.02 Million
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $1.45 Million - $1.83 Million	-7,500 Reduced 50.0%	7,500 $21,000
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $3.36 Million - $4.32 Million	15,000 New	15,000 $166,000
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $848,970 - $1.11 Million	-3,000 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$259.0 - $414.71 $777,000 - $1.24 Million	3,000 New	3,000 $19,000
Q1 2021 May 04, 2021	SELL	$242.95 - $284.63 $2.53 Million - $2.96 Million	-10,400 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$236.26 - $355.63 $2.46 Million - $3.7 Million	10,400 New	10,400 $52,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.